204 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
19 Oct 23
Current report (foreign)
1:45pm
Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
4 Oct 23
RepliCel Provides Default Status Update and Announces Shareholder Approval of Equity Incentive Plan
2:23pm
.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
3tfqzmz
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.2
vbx3swf vv5bad1n
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.1
we2dnui7km22t
7 Sep 23
Current report (foreign)
12:26pm
6-K
EX-99.2
tm1 i7qdbyxnug4a
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
6-K
EX-99.1
5dzho5f
29 Aug 23
RepliCel announces the passing of long time Chief Financial Officer Simon Ma; David Kwok is appointed Chief Financial Officer
1:14pm
6-K
EX-99.4
3d54x6 76iwtdtv
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.2
p8h4p8wlt
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.1
t34rm3vl
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.1
hgk42p3odz4jx12ykuqc
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
bjhrz
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
6-K
EX-99.1
98fw9e6
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.5
h8xc7i3uxvhv5aa3p6m9
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.2
elfjwi
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.1
05mtakhg6q4zoro 68i
25 Oct 22
Current report (foreign)
12:27pm